(87) reported that FOXO3 downregulation resulted from ERK phosphorylating sites S294, S344, and S425, and FOXO3 degradation via the ubiquitin-proteasome-dependent pathway was counteracted by MDM2, thus causing tumor cell apoptosis. This evidence concerns the gene FOXO3 and neoplasm.